World Market for Infectious Disease Immunoassays

 
   Single User - $3,500
   Site License (one location, 10 users) - $5,000
   Corporate License - $7,000



Loading...
Published Oct 5, 2017 | 180 Pages | Pub ID: KLI15498315

World Market for Infectious Disease Immunoassays

Visit our 'Immunoassays' curated page for complete coverage of the immunoassay market.

A key area of immunoassay testing is in detecting infectious diseases. The infectious disease immunoassay market is large because of the many different infectious agents affecting the population. Common infectious disease immunoassays performed in central laboratories are typically categorized into groups such as hepatitis, retroviral testing, sexually transmitted diseases, TORCH, and other infectious diseases. Infectious disease immunoassays are used in point-of-care setting or when rapid testing is needed. Immunoassays are also used to screen blood and blood products in order to prevent transfusion-transmitted infections.

Kalorama Information's report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion.


World Market for Infectious Disease Immunoassays Provides Data Including:

  • Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$))
  • Global Lab-based Infectious Disease Immunoassay Market Share % 2016
  • Lab-Based Immunoassay Market by Geographic Region 2021
  • POC Infectious Disease Immunoassay Market
  • Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  • POC Infectious Disease Immunoassay Market by Country(US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
  • Trends and Information
  • Corporate Profiles
Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays. However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.

Immunoassays for many infectious diseases are a mature market. Tests have been available for many of these agents for years or decades. Growth in this market will primarily be fueled by the identification of new infectious agents for which testing may be needed, and by growth of diagnostic testing in developing countries where infectious diseases are a major problem. Diseases such as HIV, HBV, and HCV infection are major problems worldwide, and growth of the IVD market in developing countries is fueling growth in the overall infectious disease immunoassay market. In addition, developing countries also need tests for other diseases (such as malaria and others) that are not common in the United States or Europe.


Immunoassay Company Profiles:

  • Accubiotech Co, Ltd.
  • Alere Inc
  • Arkray, Inc
  • Arlington Scientific, Inc.
  • Atlas Link Biotech Co., Ltd
  • Beckman Coulter, Inc
  • Becton Dickinson (Bd)
  • Biokit S.A.
  • Biomerieux Sa
  • Bio-Rad Laboratories Inc
  • Bioscan Screening Systems, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Diasource Immunoassays Sa
  • Elitechgroup, Inc.
  • Erba Diagnostics, Inc.
  • Grifols International S.A.
  • Hema Diagnostic Systems, Llc
  • Labsystems Diagnostics Oy
  • Luminex Corporation
  • Medix Biochemica
  • Medmira, Inc
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Novatec Immunodiagnostica Gmbh
  • Oncimmune Holdings Plc.
  • One Lambda
  • Operon
  • Orasure Technologies, Inc.
  • Quidel Corporation
  • Response Biomedical Corp
  • Savyon Diagnostics Ltd.
  • Sekisui Diagnostics
  • Siemens Healthineers
  • Standard Diagnostics, Inc.
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Trinity Biotech Plc
  • Wako Diagnostics
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.